Results 181 to 190 of about 2,752 (194)

Indacaterol provides sustained 24 h bronchodilation on once-daily dosing in asthma: a 7-day dose-ranging study

Allergy: European Journal of Allergy and Clinical Immunology, 2008
Leonardo M. Fabbri, Zaurbek Aisanov
exaly  

Dose Emission of Indacaterol from an Indacaterol Breezhaler&[reg]

2016
openaire   +1 more source

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients

Respiratory Medicine, 2014
Jadwiga A Wedzicha, Robert B. Fogel, Peter D’Andrea   +2 more
exaly  

Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler® 150 and 300 μg

AAPS PharmSciTech, 2017
Hassan Larhrib, Henry Chrystyn
exaly  

Enalapril/glycopyrrolate/indacaterol

Reactions Weekly, 2018
openaire   +1 more source

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12-week, placebo-controlled study

Respirology, 2012
Liang-Wen Hang, Yoshinosuke Fukuchi, Masaharu Kinoshita   +2 more
exaly  

Indacaterol (r)

2011
openaire   +1 more source

Acute effects of indacaterol on lung hyperinflation in moderate COPD: A comparison with tiotropium

Respiratory Medicine, 2012
Andrea Rossi, Vito Brusasco, Stefano Centanni   +2 more
exaly  

24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: A comparison with placebo and salmeterol

Respiratory Medicine, 2010
Mitsuru Adachi, Mark Higgins
exaly  

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Core Evidence, 2009
Kai-Michael Beeh
exaly